Radiation Therapy Approaches for People With Prostate Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT07751159
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- High Risk Prostate Cancer
- Non-metastatic Prostate Cancer
- Prostate Cancer Patients
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Brachytherapy — RADIATIONStandard of care Brachytherapy
- SBRT — DRUGSBRT alone
Study Details
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Key Dates
- First listed
- Aug 7, 2026
- Start date
- Jul 31, 2026
- Status verified
- Aug 2026
- Primary completion
- Jul 31, 2030
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 126 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Arm A: HDR Brachytherapy Boost + SBRTStandard of Care Brachytherapy/Radiation and SBRT
- Experimental: Arm B: SBRT AloneSBRT alone
Primary Outcome Measure
Change in International Prostate Symptom Score / IPSS at 3 months [ Time Frame: 3 months ]
Central Contacts
- Daniel Gorovets, MD212-639-3983
- Himanshu Nagar, MD212-639-6478
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering at Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Commack | New York | 11725 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | New York | 10065 | Daniel Gorovets, MD 212-639-3983 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Daniel Gorovets, MD 212-639-3983 |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering at Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering at Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering at Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activites)· New York, NY
Related Studies
- Expanding Genetic Access for Prostate Cancer SurvivorsNot Yet Recruiting · Georgetown University · Washington D.C., District of Columbia
- Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPCPHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Androgen-responsive POSLUMA-guided Intra-prostatic BoostPHASE2 · Recruiting · Martin T. King, MD, PhD · Boston, Massachusetts